- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05691686
Bread Structure and Postprandial Metabolic Responses
March 4, 2024 updated by: Amalia Yanni, Harokopio University
Effects of Less-processed Whole Grain Bread Products (Wheat and Fortified With Legumes) on Postprandial Glucose and Subsequent Metabolic Responses.
The structural properties of bread are considered one of the most important factors that can affect its digestibility, glucose homeostasis and postprandial metabolic responses.
The purpose of this study is to examine the effects of consumption of less processed whole grain bread products (wheat and fortified with legumes) in comparison with finely milled whole grain bread products on postprandial glycaemic response and appetite regulation.
Study Overview
Status
Completed
Conditions
Detailed Description
Postprandial glucose response caused by bread products of different degree of processing, as well as their appetite regulating properties will be evaluated.
In the intervention there are totally four samples, the reference (white wheat bread), the less processed whole wheat bread, the whole wheat bread fortified with finely milled legumes (chickpeas), the whole wheat bread fortified with less processed legumes (chickpeas).
The volunteers that will be enrolled in the study should be apparently healthy subjects (women and men) with normal body weight.
Certain effects related to the structure of the different products on glycemic and insulinemic responses, subjective appetite ratings and other parameters will be examined.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Attiki
-
Athens, Attiki, Greece, 17671
- Amalia Yanni
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- normal exercise and dietary habbits
- weight stable for at least 3 months before enrollment
Exclusion Criteria:
- pregnancy and lactation
- diabetes
- chronic medical illness
- regular intense exercise (>5 hrs/week)
- alcohol consumption >2 drinks/day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Finely milled whole wheat-legume bread
Treatment with finely milled whole wheat-legume bread.
|
The intervention examines the effect of finely milled wheat-legume bread in subjects with normal body weight.
|
|
Experimental: Less processed whole wheat-legume bread
Treatment with less processed whole wheat-legume bread.
|
The intervention examines the effect of less processed whole wheat-legume bread in subjects with normal body weight.
|
|
Experimental: Less processed whole wheat bread
Treatment with of less processed whole wheat bread.
|
The intervention examines the effect of less processed whole wheat bread in subjects with normal body weight.
|
|
Active Comparator: Reference Food (white wheat bread)
Treatment with reference food.
|
The intervention examines the reference food product in subjects with normal body weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in glucose incremental area under the curve (iAUC) after consumption of the breads compared to the iAUC after consumption of the reference food.
Time Frame: Time points: 0 (before food consumption), 30, 45, 60, 90,120,180 minutes postprandially (4 times in total).
|
Blood glucose concentration will be measured for each participant before and after the test foods, with blood samples being collected at specific time points: 0 (before food consumption), 30, 45, 60, 90, 120, 180 minutes postprandially for each food.
|
Time points: 0 (before food consumption), 30, 45, 60, 90,120,180 minutes postprandially (4 times in total).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective appetite ratings
Time Frame: Time points: 0 (before food consumption), 30, 60, 90,120,180 minutes postprandially (4 times in total).
|
Subjective evaluation of hunger, satiety, and desire to eat with Visual Analogue Scales, before the consumption and 30, 60, 90, 120, 180 minutes after (0-100 mm with 0 indicating no hunger or perceived ability to consume food/no satiety or no fullness).
Difference in perception of these parameters will be measured and compared between the experimental condition and the control condition.
|
Time points: 0 (before food consumption), 30, 60, 90,120,180 minutes postprandially (4 times in total).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Nikolaos Tentolouris, Professor, National and Kapodistrian University of Athens
- Study Chair: Vaios Karathanos, Professor, Harokopio University of Athens
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 16, 2023
Primary Completion (Actual)
May 15, 2023
Study Completion (Actual)
October 31, 2023
Study Registration Dates
First Submitted
December 22, 2022
First Submitted That Met QC Criteria
January 10, 2023
First Posted (Actual)
January 20, 2023
Study Record Updates
Last Update Posted (Actual)
March 5, 2024
Last Update Submitted That Met QC Criteria
March 4, 2024
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 513.26-07-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postprandial Hyperglycemia
-
San Diego State UniversityCompletedPostprandial Hyperglycemia | Postprandial Glycemic Response | Postprandial InsulinUnited States
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
San Diego State UniversityCompletedPostprandial Hyperglycemia | Postprandial InsulinUnited States
-
Clinica Universidad de Navarra, Universidad de...CompletedLipid Profile | Hyperglycemia, Postprandial | Feeding Behaviors | Antioxidant | PostprandialSpain
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
University of Eastern FinlandFinnsugar LtdCompletedHyperglycemia, PostprandialFinland
-
National University of SingaporeNational University Health System, SingaporeCompletedPostprandial HyperglycemiaSingapore
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
University of Eastern FinlandCompletedPostprandial HyperglycemiaFinland
Clinical Trials on Finely milled whole wheat-legume bread
-
University of ManitobaPulse CanadaCompleted
-
Ohio State UniversityUnited States Department of Agriculture (USDA)Active, not recruitingInflammation | PreDiabetes | Endotoxemia | DysbiosisUnited States
-
TNONederlands Bakkerij Centrum; PepsiCo, Inc.Completed
-
TC Erciyes UniversityCompleted
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
Westlake UniversityThe Third People's Hospital of HangzhouRecruiting
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece